{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:45:31Z","timestamp":1790423131802,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.carrev.2026.03.020","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T08:23:28Z","timestamp":1774599808000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Paclitaxel versus sirolimus based balloon angioplasty for in-stent restenosis: A comparison of the AGENT IDE and SELUTION4ISR Randomized Pivotal Controlled Trials"],"prefix":"10.1016","author":[{"given":"Edward T.","family":"Ha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ori","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.carrev.2026.03.020_bb0005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.15420\/ecr.2018:8:2","article-title":"The newest generation of drug-eluting stents and beyond","volume":"13","author":"Lee","year":"2018","journal-title":"Eur Cardiol"},{"issue":"C","key":"10.1016\/j.carrev.2026.03.020_bb0010","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.carrev.2024.04.001","article-title":"Editorial: Is the axiom of balloon angioplasty, \u201cthe more you gain the more you lose\u201d, still true in the era of DCB with paclitaxel?","volume":"69","author":"Serruys","year":"2024","journal-title":"Cardiovasc Revasc Med"},{"issue":"13","key":"10.1016\/j.carrev.2026.03.020_bb0015","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.jacc.2020.08.002","article-title":"Trends and outcomes of restenosis after coronary stent implantation in the United States","volume":"76","author":"Moussa","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.carrev.2026.03.020_bb0020","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jcin.2023.02.011","article-title":"Long-term outcome of drug-coated balloon vs drug-eluting stent for small coronary vessels: PICCOLETO-II 3-year follow-up","volume":"16","author":"Cortese","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.03.020_bb0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.carrev.2024.05.027","article-title":"Drug-coated balloons for coronary artery disease: An updated review with future perspectives","volume":"69","author":"Bhogal","year":"2024","journal-title":"Cardiovasc Revasc Med"},{"issue":"18","key":"10.1016\/j.carrev.2026.03.020_bb0030","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":"Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease","volume":"362","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2026.03.020_bb0035","article-title":"A pharmacokinetic comparison between three drug delivery devices in porcine coronary arteries","author":"Tanaka","year":"2025","journal-title":"Cardiovasc Revasc Med"},{"issue":"12","key":"10.1016\/j.carrev.2026.03.020_bb0040","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jama.2024.1361","article-title":"Paclitaxel-coated balloon vs uncoated balloon for coronary in-stent restenosis: The AGENT IDE randomized clinical trial","volume":"331","author":"Yeh","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2026.03.020_bb0045","article-title":"Randomized trial sirolimus-eluting balloon versus repeat drug-eluting stenting balloon angioplasty coronary in-stent restenosis","author":"Cutlip","year":"2026","journal-title":"JACC"},{"key":"10.1016\/j.carrev.2026.03.020_bb0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ahj.2021.07.008","article-title":"Rationale and design of a randomized study comparing the agent drug coated balloon to plain old balloon angioplasty in patients with In-stent restenosis","volume":"241","author":"Yeh","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2026.03.020_bb0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ahj.2025.02.001","article-title":"Prospective randomized single-blind multicenter study to assess the safety and effectiveness of the SELUTION SLR 014 drug eluting balloon in the treatment of subjects with in-stent restenosis: rationale and design","volume":"284","author":"Cutlip","year":"2025","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.carrev.2026.03.020_bb0060","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jcin.2018.11.040","article-title":"Treatment of coronary drug-eluting stent restenosis by a sirolimus- or paclitaxel-coated balloon","volume":"12","author":"Ali","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.carrev.2026.03.020_bb0065","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.122.012305","article-title":"Combined analysis of two parallel randomized trials of sirolimus-coated and paclitaxel-coated balloons in coronary in-stent restenosis lesions","volume":"15","author":"Scheller","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2026.03.020_bb0070","series-title":"Sirolimus coated balloon versus paclitaxel coated balloon angioplasty for the treatment of drug eluting stent in stent restenosis: a prospective, multicenter, randomized trial","author":"Han","year":"2023"},{"issue":"5","key":"10.1016\/j.carrev.2026.03.020_bb0075","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.124.014677","article-title":"Comparing the efficacy of sirolimus and paclitaxel-eluting balloon catheters in the treatment of coronary in-stent restenosis: a prospective randomized study (TIS 2 Study)","volume":"18","author":"Pleva","year":"2025","journal-title":"Circ Cardiovasc Interv"},{"issue":"8","key":"10.1016\/j.carrev.2026.03.020_bb0080","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jcin.2024.12.024","article-title":"Sirolimus- vs paclitaxel-coated balloon for the treatment of coronary in-stent restenosis: The SIBLINT-ISR randomized trial","volume":"18","author":"Liu","year":"2025","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.carrev.2026.03.020_bb0085","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jcin.2024.11.026","article-title":"Randomized trial of Biolimus DCB for in-stent restenosis: the primary results of the REFORM study","volume":"18","author":"Byrne","year":"2025","journal-title":"JACC Cardiovasc Interv"},{"issue":"21","key":"10.1016\/j.carrev.2026.03.020_bb0090","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.jacc.2020.04.006","article-title":"Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis","volume":"75","author":"Giacoppo","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.carrev.2026.03.020_bb0095","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005935","article-title":"Clinical outcomes of drug-eluting balloon for in-stent restenosis based on the number of metallic layers","volume":"11","author":"Yabushita","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"issue":"23","key":"10.1016\/j.carrev.2026.03.020_bb0100","article-title":"Drug-coated balloons versus drug-eluting stents or plain old balloon angioplasty: a long-term in-stent restenosis study","volume":"13","author":"von Koch","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.carrev.2026.03.020_bb0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.amjcard.2024.06.028","article-title":"Comparison of drug-coated balloons with drug-eluting stents in patients with in-stent restenosis: a systematic review and meta-analysis","volume":"227","author":"Kumar","year":"2024","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.carrev.2026.03.020_bb0110","first-page":"e18","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838926001119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838926001119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:11:33Z","timestamp":1775560293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838926001119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":22,"alternative-id":["S1553838926001119"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2026.03.020","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paclitaxel versus sirolimus based balloon angioplasty for in-stent restenosis: A comparison of the AGENT IDE and SELUTION4ISR Randomized Pivotal Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2026.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}